• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Insecticidal bed nets linked with reduced transmission of lymphatic filariasis

byMatthew Growdon
February 14, 2014
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
Insecticidal bed nets linked with reduced transmission of lymphatic filariasis
Share on FacebookShare on Twitter

Image: PD 

1. Following bed net distribution, mosquitoes infected with any stage of W. bancrofti larvae decreased from 1.8% to 0.4% (p=0.005).

2. Based on the authors’ statistical model, probability of transmission cessation was less than 1% in all villages prior to bed net distribution and increased to probabilities ranging from 4.9% to 95.8% following bed net intervention. 

Evidence Rating Level: 2 (Good) 

Study Rundown: This prevalence study investigated the effect of insecticide-impregnated bed nets on measures of filariasis transmission in Papua New Guinea.  Lymphatic filariasis, caused by W. bancrofti nematodes and affecting approximately 120 million people in Africa, Asia, the Pacific, and the Americas, has been targeted for global elimination by 2020 through the usage of mass administrations of antifilarial drugs. Recent attention has focused on the possibility of using vector control, potentially in conjunction with ongoing malaria control efforts, to augment filariasis elimination efforts.

In this study, data from before and after a 2009 nationwide mosquito bed-net effort in Papua New Guinea provide quantitative support for this notion. Following bed-net intervention in 2009, there were significantly decreased village-specific rates of mosquito bites as well as significantly decreased proportions of mosquitoes infected with the nematode causing filariasis.  Due to a lack of detectable infective nematode in mosquitoes following bed net intervention, the probability of transmission potentials dropped to zero in the five villages following the 2009 intervention. These results represent compelling epidemiological data to support incorporation of vector control through insecticide bed nets into ongoing efforts to control filariasis with antifilarial medications. Drawbacks to the study include the lack of randomization and the challenge of detecting human microfilariae infection at progressively lower levels.  Nevertheless, the results provide grounding for future studies with individual-level data and conducted in broader contexts than the villages in Papua New Guinea, as well as longer study lengths that encompass the 5-year reproductive life span of adult worms residing in human lymphatics.

RELATED REPORTS

No Content Available

Click to read the study, published today in NEJM

Relevant Reading: Determinants of success in national programs to eliminate lymphatic filariasis

In-Depth [prevalence study/entomologic survey]: This prevalence study and entomologic survey quantified the effect of deltamethrin-impregnated bed nets on measures of filariasis transmission in five villages in Papua New Guinea that had previously undergone mass antifilarial medication treatments between 1994 through 1998.  A nationwide bed-net intervention in 2009 led to an increase in self-reported bed net usage from 3.8% to 12.4% to 75.0 to 90.6% of households. 20, 345 anopheline mosquitoes were collected in the 26 months before bed-net distribution, and 1,554 in the 11 months after distribution; 2 villages were selected for long-term assessment of mosquito biting rates up to 3 years following intervention. Following bed net distribution, mosquitoes infected with any stage of W. bancrofti larvae decreased from 1.8% to 0.4% (P=0.005); no mosquitoes with infective larvae were identified in any villages after bed-net distribution (P=0.07). Furthermore, the annual transmission potential for lymphatic filariasis to drop to zero in the post-bed net period.

Using a numerical-modeling and Bayesian analysis method based on the mosquito-biting rate and the prevalence of microfilariae measured in villagers prior to the bed-net intervention, the study authors calculated the probabilities of cessation of transmission of filariasis in the 5 villages. Daily biting rates of mosquitoes decreased significantly in all 5 villages (p<0.001 for all comparisons).  According to the model, probability of transmission cessation was less than 1% in all villages prior to bed-net distribution and increased to probabilities ranging from 4.9% to 95.8% following the 2009 intervention.  Probabilities of transmission cessation tended to be higher in those villages where levels of microfilariae detectable in human blood were lower from the outset, suggesting a role for mass medication interventions in tandem with vector control efforts.

More from this author: Alternative treatment for acute promyelocytic leukemia promising, The CHEST-1 & PATENT-1: Riociguat significantly improves exercise capacity in pulmonary hypertension patients, High glucose levels associated with increased risk of dementia

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

Tags: bed netsfilariasis
Previous Post

Low diastolic blood pressure associated with higher mortality in chronic kidney disease

Next Post

Diabetic patients report improved vision after ranibizumab treatment

RelatedReports

No Content Available
Next Post
Diabetic patients report improved vision after ranibizumab treatment

Diabetic patients report improved vision after ranibizumab treatment

Remote ischemic preconditioning reduced myocardial injury in CABG patients

Remote ischemic preconditioning reduced myocardial injury in CABG patients

Fruit consumption linked to lower risk of abdominal aortic aneurysms

Fruit consumption linked to lower risk of abdominal aortic aneurysms

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases
  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.